Diabetes? • Live carefree with smart technology!

In the middle of life – despite diabetes

Job, family, sport, demands, changes – life is colorful and can sometimes be quite a rollercoaster. That is exactly what blood sugar is not supposed to do. Systems for continuous tissue glucose measurement (rtCGM) such as the Dexcom G6 can help to prevent the blood sugar level from traveling along the roller track: The tissue sugar is measured automatically every five minutes in real time, which gives people with diabetes more security. Today, rtCGM systems enable freedom that would have been unthinkable just a few years ago – and thus the possibility of leading a self-determined life – despite diabetes. With the Dexcom G6, those affected can better understand their illness, manage it independently and, last but not least, prevent serious glycemic events such as hypoglycemia or hypoglycemia every day.^2,3,4 And that can help reduce the risk of complications.

REALLY networked and future-proof: Dexcom G6 gives more security

Smart diabetes technologies such as the Dexcom G6 rtCGM system can make things easier and more secure at the same time: Because pricking blood sugar is a thing of the past. The Dexcom G6 measures via a sensor without finger pricks * or continuously scans the tissue sugar and sends these values ​​automatically every five minutes to a compatible smartphone⁵, a smartwatch^5.6 or the user's optional receiving device – and has arrived in the middle of the digital age.

This means that the values ​​do not need to be scanned, as is the case with other systems for measuring glucose. In case of doubt, the winter jacket can remain on, a glance at the smartphone is enough. The user receives an alarm in the event of acute hypoglycemia and hypoglycemia so that safety and rapid therapy optimization can be guaranteed. In addition, a hypo-warning offers the possibility of avoiding hypoglycaemia by issuing a warning 20 minutes in advance. If you now eat carbohydrates quickly at this early stage, you can prevent acute hypoglycaemia. People with diabetes gain more security and can concentrate on their daily challenges – which can be a great relief in work or family life.

With the rtCGM system, you can also create an individual alarm plan that is tailored to your individual needs^7th create: This takes into account the time of day and night, work and leisure time, or regularly recurring events such as sports training. The SHARE function of the Dexcom G6^8th Wearers of the G6 system can continuously share their measured values ​​and warnings with relatives. This also calms loved ones or supports them in looking after children.

Well taken care of: pregnancy and diabetes

Even expectant mothers with diabetes cannot use the additional stress of unexpected hypoglycemia and hypoglycemia. Because pregnancy is adventure enough. Meeting the strict targets can be quite a challenge for mothers-to-be. Now it is a little easier: The use of an rtCGM during pregnancy is now expressly recommended by the Federal Joint Committee (G-BA).⁹ Dexcom goes with you. Because the smart sensor can officially be worn in the most exciting time of life to support diabetes – this is how mothers-to-be, children and relatives benefit from the advantages that rtCGM enables.

And: Even more relief in diabetes therapy – not only for pregnant women – is made possible by the new combination of Dexcom G6 sensor and insulin pump!

Did you know that?

Currently, around 225,000 patients with statutory health insurance are enrolled in a Disease Management Program (DMP) for type 1 diabetes¹⁰ and are thus treated in accordance with the latest medical research. For those affected by diabetes, this also means that, under certain circumstances, for example, if the therapy goals are not achieved, severe hypoglycaemia, ketoacidosis (severe metabolic imbalances due to insulin deficiency) and during pregnancy, a right to reimbursement of an rtCGM- Systems.¹¹

REALLY well informed: New online series of events

Diabetes professionals working together for patients: Dexcom, in collaboration with Charité Berlin, has launched a digital series of events – D-Talk. Experts and people with diabetes provide information on selected topics related to the disease – and from the heart of life. Further information is available here!

_{* If the glucose warnings and readings on the G6 System do not meet symptoms or expectations, the patient should use a blood glucose meter to make treatment decisions about their diabetes.}

_{(1) https://www.diabetesde.org/ueber_diabetes/was_ist_diabetes_/diabetes_in_zahlen}

_{(2) Beck RW et al. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomized controlled trial. Lancet Diabetes Endocrinol. 2017 Sep; 5 (9): 700-708.}

_{(3) Beck RW et al. Continuous glucose monitoring vs usual care in type 2 diabetes on multiple daily injections: a randomized trial. Ann Int Med. 2017 Sep 19; 167 (6): 365-374.}

_{(4) Reddy M et al. A Randomized Controlled Pilot Study of Continuous Glucose Monitoring in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia. Diabet Med. 2018 Apr; 35 (4): 483-490.}

_{(5) List of compatible devices at www.dexcom.com/compatibility}

_{(6) The transfer of the glucose values ​​to a compatible smartwatch requires the simultaneous use of a compatible smartphone.}

_{(7) The creation of an individual alarm plan is only possible with a compatible smartphone, not with the Dexcom G6 receiver device and should always be done in consultation with the treating diabetologist.}

_{(8) An internet connection is required to transfer data. Use of the Follow App is required to follow. Users should not use the SHARE and Follow app values, but rather only the data from the Dexcom app or the recipient to make treatment decisions. A list of compatible devices can be found at www.dexcom.com/compatibility}

_{(9) Resolution of the Federal Joint Committee of January 16, 2020 on the 20th amendment to the DMP Requirements Directive (DMP-A-RL): amendment to Annex 7 (DMP Diabetes mellitus type 1 and Annex 8 (DMP Diabetes mellitus type 1 and type 2 documentation).}

_{(10) Federal Joint Committee (G-BA): Press release – DMP for patients with type 1 diabetes updated. https://www.g-ba.de/presse/pressemitteilungen/840/. Last visited on 03.11.2020}

_{(11) Resolution of the Federal Joint Committee of January 16, 2020 on the 20th amendment to the DMP Requirements Directive (DMP-A-RL): amendment to Annex 7 (DMP diabetes mellitus type 1 and Annex 8 (DMP diabetes mellitus type 1 and type 2 documentation).}

_{LBL020310 Rev001}